Hypoxia inducible factor-1α drives cancer resistance to cuproptosis
Zhou Yang(Fudan University Shanghai Cancer Center), Wei Su(Fudan University Shanghai Cancer Center), Xiyi Wei(Jiangsu Province Hospital), Yitong Pan(Chinese Academy of Sciences), Mengying Xing(Nanjing University), Lili Niu(Tongji University), Baijie Feng(Pudong Medical Center), Weiyu Kong(Jiangsu Province Hospital), Xiaohan Ren(Jiangsu Province Hospital), Feng Huang(Nanjing Medical University), Jingwan Zhou(Nanjing Medical University), Wei Zhao(First Affiliated Hospital of Chengdu Medical College), Yan-Yu Qiu(Nanjing Medical University), Tian Liao(Fudan University Shanghai Cancer Center), Quan Chen(Fudan University Shanghai Cancer Center), Shuang Qu(Nanjing Medical University), Yunjun Wang(Fudan University Shanghai Cancer Center), Qing Guan(Fudan University Shanghai Cancer Center), Duanshu Li(Fudan University Shanghai Cancer Center), Zen Ke(Nanjing University), Yun Chen(Nanjing Medical University), Chao Qin(Nanjing Medical University), Yu Wang(Fudan University Shanghai Cancer Center), Xiang Zhou(Fudan University Shanghai Cancer Center), Jun Xiang(Fudan University Shanghai Cancer Center), Bing Yao(Nanjing Medical University)
Cited by 110
Abstract
Related Papers
The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation
Markus Welcker, Amir Orian, Jianping Jin et al.|Proceedings of the National Academy of Sciences|2004|943